Cargando…
The Crystal Structure of the R280K Mutant of Human p53 Explains the Loss of DNA Binding
The p53 tumor suppressor is widely found to be mutated in human cancer. This protein is regarded as a molecular hub regulating different cell responses, namely cell death. Compelling data have demonstrated that the impairment of p53 activity correlates with tumor development and maintenance. For the...
Autores principales: | Gomes, Ana Sara, Trovão, Filipa, Andrade Pinheiro, Benedita, Freire, Filipe, Gomes, Sara, Oliveira, Carla, Domingues, Lucília, Romão, Maria João, Saraiva, Lucília, Carvalho, Ana Luísa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979565/ https://www.ncbi.nlm.nih.gov/pubmed/29652801 http://dx.doi.org/10.3390/ijms19041184 |
Ejemplares similares
-
Structural and Drug Targeting Insights on Mutant p53
por: Gomes, Ana Sara, et al.
Publicado: (2021) -
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma
por: Gomes, Sara, et al.
Publicado: (2019) -
DIMP53‐1: a novel small‐molecule dual inhibitor of p53–MDM2/X interactions with multifunctional p53‐dependent anticancer properties
por: Soares, Joana, et al.
Publicado: (2017) -
Cytotoxicity of Frutalin on Distinct Cancer Cells Is Independent of Its Glycosylation
por: Oliveira, Carla, et al.
Publicado: (2021) -
Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule
por: Soares, Joana, et al.
Publicado: (2015)